Faculty of Medicine and University Hospital Cologne, Institute for Health Economics and Clinical Epidemiology, University of Cologne, Cologne, Germany.
Faculty of Medicine and University Hospital Cologne, Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Cologne, Germany.
J Genet Couns. 2022 Jun;31(3):698-712. doi: 10.1002/jgc4.1536. Epub 2021 Nov 26.
With 69,000 newly diagnosed cases every year, breast cancer (BC) is the most frequent cancer disease among women in Germany. Familial clustering is seen in about 30% of newly diagnosed cases. Besides the high-risk genes BRCA1/2, there are also moderate-risk BC genes (MBCG) that are associated with a 20%-50% risk of BC, such as CHEK2, ATM, and PALB2. In Germany, carriers of pathogenic variants in MBCG receive specific information on their test results, individual risks, and preventive options during genetic counseling for the disclosure of the results in a specialized center. Little is known about the medical knowledge that women have after attending counseling. This study aims to identify the medical knowledge, further information needs, and the possible impact of a lack of information on dealing with everyday life for women with pathogenic variants in MBCG who have attended genetic counseling at an academic hospital in Germany. Problem-centered, guided, individual interviews were conducted with twelve women carrying pathogenic variants in MBCG. The interview guide was developed based on the methods of the problem-centered interview according to Witzel. The interview analysis was based on Mayring's qualitative content analysis. The women were between 29 and 59 years old and carried pathogenic variants in the risk genes CHEK2 (n = 8), ATM (n = 1), or PALB2 (n = 3). Several medical uncertainties and information needs emerged from the data, concerning (a) medical terms, (b) risk perception, (c) BC therapy for hereditary BC, (d) lifestyle advice and risk factors, and (e) family planning and risk-reducing mastectomy. Women with pathogenic variants in MBCG might develop their own conceptions regarding the onset of disease and inheritance. In order to meet the need for information and address the uncertainties that may still exist after genetic counseling, structured, evidence-based and comprehensible written information in German should be developed for this group.
每年有 69,000 例新诊断病例,乳腺癌 (BC) 是德国女性中最常见的癌症疾病。大约 30%的新诊断病例存在家族聚集现象。除了高风险基因 BRCA1/2 外,还有一些中度风险的乳腺癌基因 (MBCG),这些基因与 20%-50%的乳腺癌风险相关,如 CHEK2、ATM 和 PALB2。在德国,MBCG 致病性变异携带者在遗传咨询时会收到关于其检测结果、个体风险和预防选择的特定信息,这些信息会在专门的中心公布。然而,关于女性在咨询后获得的医学知识知之甚少。本研究旨在确定在德国一家学术医院进行遗传咨询后,携带 MBCG 致病性变异的女性在医学知识、进一步的信息需求以及缺乏信息对其日常生活处理的可能影响。采用以问题为中心、指导性、个体访谈的方法,对 12 名携带 MBCG 致病性变异的女性进行了访谈。访谈指南是根据 Witzel 的问题中心访谈方法制定的。访谈分析基于 Mayring 的定性内容分析。这些女性年龄在 29 至 59 岁之间,携带 CHEK2 风险基因 (n=8)、ATM (n=1) 或 PALB2 (n=3) 的致病性变异。从数据中出现了几个医学不确定性和信息需求,涉及 (a) 医学术语、(b) 风险感知、(c) 遗传性 BC 的 BC 治疗、(d) 生活方式建议和风险因素、以及 (e) 计划生育和降低风险的乳房切除术。携带 MBCG 致病性变异的女性可能会对疾病的发病和遗传产生自己的概念。为了满足信息需求,并解决遗传咨询后可能仍然存在的不确定性,应针对这一群体制定基于证据、有组织且易于理解的德文书面信息。